...
csbr-img

Champions Oncology Inc, Common Stock

CSBR

NAQ

$7.505

-$0.04

(-0.53%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$103.43M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
117.67K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.49
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.6 L
$7.85 H
$7.505

About Champions Oncology Inc, Common Stock

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameCSBRSectorS&P500
1-Week Return18.56%-2.12%-3%
1-Month Return73.73%-3.42%-0.73%
3-Month Return57.34%-11.13%2.87%
6-Month Return55.38%-5.74%7.17%
1-Year Return51.01%3.97%25.31%
3-Year Return-8.36%1.05%28.38%
5-Year Return0.47%34.37%81.89%
10-Year Return56.35%97.88%183.27%

Financials

Apr '20Apr '21Apr '22Apr '23Apr '245YR TREND
Total Revenue32.12M41.04M49.11M53.87M50.16M[{"date":"2020-04-30","value":59.63,"profit":true},{"date":"2021-04-30","value":76.18,"profit":true},{"date":"2022-04-30","value":91.16,"profit":true},{"date":"2023-04-30","value":100,"profit":true},{"date":"2024-04-30","value":93.1,"profit":true}]
Cost of Revenue16.88M21.47M23.63M29.53M29.40M[{"date":"2020-04-30","value":57.17,"profit":true},{"date":"2021-04-30","value":72.71,"profit":true},{"date":"2022-04-30","value":80.02,"profit":true},{"date":"2023-04-30","value":100,"profit":true},{"date":"2024-04-30","value":99.56,"profit":true}]
Gross Profit15.24M19.57M25.48M24.34M20.75M[{"date":"2020-04-30","value":59.82,"profit":true},{"date":"2021-04-30","value":76.8,"profit":true},{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":95.53,"profit":true},{"date":"2024-04-30","value":81.46,"profit":true}]
Gross Margin47.45%47.68%51.88%45.18%41.38%[{"date":"2020-04-30","value":91.46,"profit":true},{"date":"2021-04-30","value":91.9,"profit":true},{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":87.09,"profit":true},{"date":"2024-04-30","value":79.76,"profit":true}]
Operating Expenses16.71M19.23M24.87M28.79M28.11M[{"date":"2020-04-30","value":58.04,"profit":true},{"date":"2021-04-30","value":66.79,"profit":true},{"date":"2022-04-30","value":86.39,"profit":true},{"date":"2023-04-30","value":100,"profit":true},{"date":"2024-04-30","value":97.65,"profit":true}]
Operating Income(1.47M)338.00K607.00K(4.45M)(7.36M)[{"date":"2020-04-30","value":-241.85,"profit":false},{"date":"2021-04-30","value":55.68,"profit":true},{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":-732.95,"profit":false},{"date":"2024-04-30","value":-1211.86,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true}]
Pre-Tax Income(1.84M)409.00K583.00K(5.27M)(7.31M)[{"date":"2020-04-30","value":-316.47,"profit":false},{"date":"2021-04-30","value":70.15,"profit":true},{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":-903.43,"profit":false},{"date":"2024-04-30","value":-1253.52,"profit":false}]
Income Taxes130.00K75.00K35.00K68.00K(32.00K)[{"date":"2020-04-30","value":100,"profit":true},{"date":"2021-04-30","value":57.69,"profit":true},{"date":"2022-04-30","value":26.92,"profit":true},{"date":"2023-04-30","value":52.31,"profit":true},{"date":"2024-04-30","value":-24.62,"profit":false}]
Income After Taxes-----[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true}]
Income From Continuous Operations(1.98M)334.00K548.00K(5.33M)(7.28M)[{"date":"2020-04-30","value":-360.4,"profit":false},{"date":"2021-04-30","value":60.95,"profit":true},{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":-973.54,"profit":false},{"date":"2024-04-30","value":-1327.74,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true}]
Net Income(1.98M)362.00K548.00K(5.33M)(7.28M)[{"date":"2020-04-30","value":-360.4,"profit":false},{"date":"2021-04-30","value":66.06,"profit":true},{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":-973.54,"profit":false},{"date":"2024-04-30","value":-1327.74,"profit":false}]
EPS (Diluted)(0.14)0.020.03(0.39)(0.49)[{"date":"2020-04-30","value":-466.67,"profit":false},{"date":"2021-04-30","value":67,"profit":true},{"date":"2022-04-30","value":100,"profit":true},{"date":"2023-04-30","value":-1304,"profit":false},{"date":"2024-04-30","value":-1633.33,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CSBR
Cash Ratio 0.15
Current Ratio 0.75

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CSBR
ROA (LTM) -6.93%
ROE (LTM) -432.46%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CSBR
Debt Ratio Lower is generally better. Negative is bad. 0.97
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.03

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CSBR
Trailing PE NM
Forward PE 22.88
P/S (TTM) 2.00
P/B 141.21
Price/FCF NM
EV/R 1.87
EV/Ebitda 69.91
PEG NM

FAQs

What is Champions Oncology Inc share price today?

Champions Oncology Inc (CSBR) share price today is $7.505

Can Indians buy Champions Oncology Inc shares?

Yes, Indians can buy shares of Champions Oncology Inc (CSBR) on Vested. To buy Champions Oncology Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CSBR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Champions Oncology Inc be purchased?

Yes, you can purchase fractional shares of Champions Oncology Inc (CSBR) via the Vested app. You can start investing in Champions Oncology Inc (CSBR) with a minimum investment of $1.

How to invest in Champions Oncology Inc shares from India?

You can invest in shares of Champions Oncology Inc (CSBR) via Vested in three simple steps:

  • Click on Sign Up or Invest in CSBR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Champions Oncology Inc shares
What is Champions Oncology Inc 52-week high and low stock price?

The 52-week high price of Champions Oncology Inc (CSBR) is $7.85. The 52-week low price of Champions Oncology Inc (CSBR) is $3.6.

What is Champions Oncology Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Champions Oncology Inc (CSBR) is

What is Champions Oncology Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Champions Oncology Inc (CSBR) is 141.21

What is Champions Oncology Inc dividend yield?

The dividend yield of Champions Oncology Inc (CSBR) is 0.00%

What is the Market Cap of Champions Oncology Inc?

The market capitalization of Champions Oncology Inc (CSBR) is $103.43M

What is Champions Oncology Inc’s stock symbol?

The stock symbol (or ticker) of Champions Oncology Inc is CSBR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top